Loading...

NEURONAL CEROID LIPOFUSCINOSIS GENE PANEL BY NGS, EDTA BLOOD

image not found

NABL Cap Accredited 
The Neuronal Ceroid Lipofuscinosis (NCL) Gene Panel by NGS evaluates multiple genes associated with a group of progressive neurodegenerative disorders known as NCLs.
This test helps identify the underlying genetic cause in individuals showing symptoms such as seizures, developmental regression, or vision loss.
Using advanced sequencing methods, Metropolis Healthcare ensures accurate detection of both common and rare mutations.
The results support early diagnosis, better management planning, and informed genetic counseling for affected families.
This comprehensive panel is ideal for clinicians investigating suspected NCL cases 

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 21,000.00

Sample Type: EDTA BLOOD

Fasting Not Required


Notes:G0226

Frequently Asked Questions (FAQ's):

What does the NCL Gene Panel by NGS include?
This panel covers key genes linked to different types of neuronal ceroid lipofuscinosis, analyzed with high-depth sequencing at Metropolis Healthcare.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses next-generation sequencing to accurately detect pathogenic variants and ensure high-quality genomic interpretation.

Who should consider taking this test?
Individuals with symptoms like seizures, cognitive decline, motor difficulties, or early vision problems may benefit from this evaluation at Metropolis Healthcare.

Why is genetic testing important for suspected NCL cases?
Genetic confirmation helps classify the specific NCL type, enabling Metropolis Healthcare to support proper treatment planning and counseling.

What sample is required for this test at Metropolis Healthcare?
A simple EDTA blood sample is sufficient for performing the NGS-based analysis.

How long does it take to receive the results?
Metropolis Healthcare generally provides results within a few weeks, depending on sequencing and analysis requirements.

Can this panel detect both childhood and adult-onset NCL forms?
Yes, the test covers genes associated with various NCL subtypes, enabling Metropolis Healthcare to identify early- and late-onset forms.

Does Metropolis Healthcare offer support after receiving the results?

Yes, counseling and expert interpretation are available to help families understand the diagnosis and explore next steps 

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab